PH Modification of Human T-type Calcium Channel Gating
Overview
Authors
Affiliations
External pH (pH(o)) modifies T-type calcium channel gating and permeation properties. The mechanisms of T-type channel modulation by pH remain unclear because native currents are small and are contaminated with L-type calcium currents. Heterologous expression of the human cloned T-type channel, alpha1H, enables us to determine the effect of changing pH on isolated T-type calcium currents. External acidification from pH(o) 8.2 to pH(o) 5.5 shifts the midpoint potential (V(1/2)) for steady-state inactivation by 11 mV, shifts the V(1/2) for maximal activation by 40 mV, and reduces the voltage dependence of channel activation. The alpha1H reversal potential (E(rev)) shifts from +49 mV at pH(o) 8.2 to +36 mV at pH(o) 5.5. The maximal macroscopic conductance (G(max)) of alpha1H increases at pH(o) 5.5 compared to pH(o) 8.2. The E(rev) and G(max) data taken together suggest that external protons decrease calcium/monovalent ion relative permeability. In response to a sustained depolarization alpha1H currents inactivate with a single exponential function. The macroscopic inactivation time constant is a steep function of voltage for potentials < -30 mV at pH(o) 8.2. At pH(o) 5.5 the voltage dependence of tau(inact) shifts more depolarized, and is also a more gradual function of voltage. The macroscopic deactivation time constant (tau(deact)) is a function of voltage at the potentials tested. At pH(o) 5.5 the voltage dependence of tau(deact) is simply transposed by approximately 40 mV, without a concomitant change in the voltage dependence. Similarly, the delay in recovery from inactivation at V(rec) of -80 mV in pH(o) 5.5 is similar to that with a V(rec) of -120 mV at pH(o) 8.2. We conclude that alpha1H is uniquely modified by pH(o) compared to other calcium channels. Protons do not block alpha1H current. Rather, a proton-induced change in activation gating accounts for most of the change in current magnitude with acidification.
Stringer R, Cmarko L, Zamponi G, De Waard M, Weiss N Mol Brain. 2023; 16(1):68.
PMID: 37735453 PMC: 10515227. DOI: 10.1186/s13041-023-01058-2.
Investigation of Cav3.3 Dysfunction in Hemiplegic Migraine.
Maksemous N, Blayney C, Sutherland H, Smith R, Lea R, Tran K Front Mol Neurosci. 2022; 15:892820.
PMID: 35928792 PMC: 9345121. DOI: 10.3389/fnmol.2022.892820.
Kittl M, Winklmayr M, Preishuber-Pflugl J, Strobl V, Gaisberger M, Ritter M Front Cell Dev Biol. 2022; 9:804105.
PMID: 35186954 PMC: 8847443. DOI: 10.3389/fcell.2021.804105.
Duzhyy D, Voitenko N, Belan P Front Cell Neurosci. 2021; 15:723295.
PMID: 34733139 PMC: 8558483. DOI: 10.3389/fncel.2021.723295.
Cens T, Rousset M, Charnet P Pflugers Arch. 2011; 462(2):303-14.
PMID: 21611731 DOI: 10.1007/s00424-011-0974-x.